Through
1/1
Cancer Research
COVID’s impact on cancer care comes more into focus
COVID’s impact on cancer care comes more into focus
With the disruption of cancer care since the pandemic began in March 2020, recent reports are starting to show that the interruption—while still significant—may not be as detrimental as experts originally feared.
Ingredient in Indian long pepper shows promise against brain cancer
Ingredient in Indian long pepper shows promise against brain cancer
Penn scientists use cryo-electron microscopy to illuminate how a chemical compound found in the plant, piperlongumine, works against glioblastoma.
Four Penn faculty elected to the National Academy of Sciences
Four Penn faculty elected to the National Academy of Sciences
The new members of the Academy, honored scholars recognized for their unique and ongoing contributions to original research, include researchers from the Perelman School of Medicine, School of Engineering and Applied Science, and Annenberg School for Communication.
Immunotherapy alone extended life for certain metastatic lung cancer patients
Immunotherapy alone extended life for certain metastatic lung cancer patients
Penn Medicine researchers show that patients harboring a KRAS gene mutation with high levels of PDL-1 lived longer when treated with immunotherapy alone, compared to patients without this mutation.
Mysterious ‘nuclear speckle’ cell structures may help block cancers
Mysterious ‘nuclear speckle’ cell structures may help block cancers
A new study out of Penn Medicine shows that the tumor-suppressor protein p53 brings speckles and DNA together to boost gene expression.
Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments.
Cancer cell therapy pioneer Carl June receives the Sanford Lorraine Cross Award
Cancer cell therapy pioneer Carl June receives the Sanford Lorraine Cross Award
The Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and director of the Center for Cellular Immunotherapies at Penn’s Abramson Cancer Center received the award for his work in developing chimeric antigen receptor (CAR) T cell therapy.
Penn Medicine cancer cell therapy pioneer Carl June named 2021 Dan David Prize Laureate
Penn Medicine cancer cell therapy pioneer Carl June named 2021 Dan David Prize Laureate
The Richard W. Vague professor in Immunotherapy in the department of Pathology and Laboratory Medicine has been recognized in the “future” category for his contributions to molecular medicine.
Take-at-home tests boost colorectal cancer screening tenfold
Take-at-home tests boost colorectal cancer screening tenfold
By making it the default to send screening tests to patients’ homes unless they opted out via text message, screening rates increased by more than 1000%.
Patients in cancer remission at high risk for severe COVID-19 illness
Patients in cancer remission at high risk for severe COVID-19 illness
Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, with Black cancer patients twice as likely to test positive for the virus.
In the News
HealthDay
Keto diet supplement could boost a cancer treatment's effectiveness
A study by Perelman School of Medicine student Puneeth Guruprasad and postdoc Shan Liu suggests that a component of the keto diet could boost CAR T cell therapy to help treat cancer.
FULL STORY →
Forbes
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Philadelphia Inquirer
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
PhillyVoice
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
The New York Times
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
Today
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →